Marker Therapeutics, Inc. (MRKR)
NASDAQ · Healthcare
Marker Therapeutics, Inc. Shareholder Equity 2017–2025
Marker Therapeutics, Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Marker Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were 16.8M, a 9.49% decrease year-over-year.
- Marker Therapeutics, Inc. shareholder equity for 2025 were 16.8M, a 9.49% decrease from 2024.
- Marker Therapeutics, Inc. shareholder equity for 2024 were 18.6M, a 32.06% increase from 2023.
- Marker Therapeutics, Inc. shareholder equity for 2023 were 14.1M, a 28.31% decrease from 2022.
- Marker Therapeutics, Inc. shareholder equity for 2022 were 19.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Marker Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $19 |
| 2023 | $14 |
| 2022 | $20 |
| 2021 | $44 |
| 2020 | $27 |
| 2019 | $44 |
| 2018 | $59 |
| 2017 | $4 |
| Marker Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $17 |
| 2024-12-31 | $19 |
| 2023-12-31 | $14 |
| 2022-12-31 | $20 |
| 2021-12-31 | $44 |
| 2020-12-31 | $27 |
| 2019-12-31 | $44 |
| 2018-12-31 | $59 |
| 2017-12-31 | $4 |
Marker Therapeutics, Inc. Shareholder Equity — FAQ
Marker Therapeutics, Inc. (MRKR) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRKR's shareholder equity history?
The chart and table above show Marker Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.